Spinal cancer is a rare type of cancer that develops in or around the spinal cord, spinal nerves, or the bones and tissues that make up the spine.

At Bay Biosciences, we provide high-quality spinal cancer samples for research, including serum, plasma, and peripheral blood mononuclear cells (PBMCs) from patients diagnosed with spinal cancer.

These spinal cancer biospecimens support pharmaceutical, biotechnology, and academic research, including biomarker studies, drug discovery, and therapeutic development.

Understanding Spinal Cancer

Spinal cancer refers to malignant tumors that develop in or around the spinal column. These tumors may affect the vertebrae, spinal cord, or tissues surrounding the spinal cord.

Spinal tumors can be either primary or secondary.

Primary spinal tumors begin in the spine or nearby tissues. In contrast, secondary spinal tumors develop when cancer from another part of the body spreads to the spinal column.

The spinal column consists of the vertebrae, spinal cord, and surrounding tissues. The vertebrae provide structural support and protect the spinal cord, while the spinal cord carries nerve signals between the brain and the rest of the body.

Spinal Cancer Samples for Research

Symptoms of Spinal Cancer

The symptoms of spinal cancer can vary depending on the location and size of the tumor. Some tumors may cause symptoms by putting pressure on the spinal cord or nearby nerves.

Common symptoms include:

Types of Spinal Tumors

These are some of the types of spinal tumors:

  • Chordoma: A malignant tumor that commonly develops in the lower spine or near the base of the skull.
  • Meningioma: A tumor that develops from the meninges, the protective layers surrounding the spinal cord and brain.
  • Glioblastoma: An aggressive malignant tumor that can develop from astrocytes and affect the central nervous system.
  • Osteosarcoma: A malignant bone tumor that can occasionally develop in the spine.
  • Spinal hemangioma: A tumor involving blood vessels within the spinal column that is usually benign.
  • Neurofibroma: A usually benign tumor that develops along nerves.
  • Schwannoma: A usually benign tumor that develops from cells surrounding nerve fibers.

Metastatic Spinal Cancer

Many spinal tumors are metastatic, meaning they develop when cancer spreads from another part of the body to the spine.

Cancers that commonly spread to the spinal column include:

Risk Factors for Spinal Cancer

The exact causes of most primary spinal tumors are not fully understood. Researchers continue to investigate the genetic and cellular changes that may contribute to tumor development.

However, several factors may increase the risk of developing certain spinal tumors.

These include:

  • Neurofibromatosis type 2
  • Von Hippel-Lindau disease
  • Certain inherited genetic changes
  • A previous diagnosis of cancer
  • Cancers that commonly metastasize to the spine

Diagnosis of Spinal Cancer

Doctors use several tests to diagnose spinal tumors and determine their location and characteristics. The diagnostic approach depends on the patient’s symptoms and medical history.

A physical and neurological examination may help identify changes in movement, sensation, reflexes, and muscle strength. Doctors may then use imaging tests to examine the spine and surrounding tissues.

Imaging tests may include X-rays, computed tomography (CT) scans, and magnetic resonance imaging (MRI). MRI is particularly useful for examining the spinal cord, nerves, and soft tissues.

A biopsy may also be performed when doctors need to examine tumor cells and determine the specific type of tumor. Laboratory testing of tissue can help distinguish between different spinal tumors and guide treatment decisions.

Staging and Grading of Spinal Cancer

Spinal cancer does not always follow the same staging system used for other cancers. Doctors may use tumor grading to describe the characteristics and growth rate of primary spinal tumors.

The grades generally include:

  • Grade I: A slow-growing tumor with relatively benign features.
  • Grade II: A tumor with abnormal cells that may grow into nearby tissues.
  • Grade III: A malignant tumor that grows more rapidly and may spread to nearby tissues.
  • Grade IV: A highly malignant and rapidly growing tumor.

Treatment of Spinal Cancer

Treatment for spinal cancer depends on several factors, including the tumor type, location, size, grade, whether it has spread, and the patient’s overall health.

Surgery is often considered when the tumor can be safely removed. The goal may be to remove the tumor, relieve pressure on the spinal cord, and preserve neurological function.

Doctors may also recommend radiation therapy to destroy or control cancer cells that cannot be removed completely through surgery.

Radiation therapy may also help manage symptoms caused by metastatic tumors.

Chemotherapy may be used for certain types of spinal tumors or when the cancer has spread from another part of the body.

Targeted therapies may also be considered when specific molecular characteristics are identified.

In addition, doctors may recommend medicines and supportive therapies to manage symptoms such as pain and neurological problems.

FAQs

What are spinal cancer samples used for?

Spinal cancer samples can be used for cancer research, biomarker discovery, molecular profiling, immune response studies, drug discovery, and therapeutic development.

What types of spinal cancer samples are available?

Researchers may use spinal tumor samples, spinal tumor tissue samples, spinal cancer serum samples, spinal cancer plasma samples, and spinal cancer PBMC samples for different research applications.

What are spinal tumor tissue samples used for?

Spinal tumor tissue samples can help researchers study tumor morphology, molecular changes, genetic alterations, tumor biology, and potential therapeutic targets.

Why are spinal cancer serum samples important for research?

Spinal cancer serum samples contain circulating proteins, antibodies, cytokines, and other biological molecules that can be studied for biomarker discovery and disease-related research.

Supporting Your Research with Bay Biosciences